Elevance Health Inc
ELV346.980USD
+5.130+1.50%
Handelsschluss 01/29, 16:00（ET）Kurse um 15 Minuten verzögert
77.11BMarktkapitalisierung
13.76KGV TTM
mehr Informationen über Elevance Health Inc Unternehmen
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Elevance Health Inc Informationen
BörsenkürzelELV
Name des UnternehmensElevance Health Inc
IPO-datumOct 30, 2001
CEOBoudreaux (Gail K)
Anzahl der mitarbeiter103158
WertpapierartOrdinary Share
GeschäftsjahresendeOct 30
Addresse220 Virginia Avenue
StadtINDIANAPOLIS
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl46204
Telefon18003311476
Websitehttps://www.elevancehealth.com/
BörsenkürzelELV
IPO-datumOct 30, 2001
CEOBoudreaux (Gail K)
Führungskräfte von Elevance Health Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+601.00%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+601.00%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+601.00%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+65.00%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
1.65K
+601.00%
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Independent Director
Independent Director
639.00
+639.00%
Mr. Robert L. Dixon, Jr.
Mr. Robert L. Dixon, Jr.
Independent Director
Independent Director
--
--
Mr. Lewis (Lew) Hay, III
Mr. Lewis (Lew) Hay, III
Independent Director
Independent Director
--
--
Mr. Peter D. (Pete) Haytaian
Mr. Peter D. (Pete) Haytaian
Executive Vice President and President, Carelon and CarelonRx
Executive Vice President and President, Carelon and CarelonRx
--
--
Mr. R. Kerry Clark
Mr. R. Kerry Clark
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ramiro G. Peru
Mr. Ramiro G. Peru
Independent Chairman of the Board
Independent Chairman of the Board
9.35K
+601.00%
Mr. Antonio F. Neri
Mr. Antonio F. Neri
Independent Director
Independent Director
4.92K
+601.00%
Dr. Bahija Jallal, Ph.D.
Dr. Bahija Jallal, Ph.D.
Independent Director
Independent Director
4.79K
+601.00%
Mr. Ronald W. Penczek
Mr. Ronald W. Penczek
Chief Accounting Officer, Controller
Chief Accounting Officer, Controller
1.69K
+65.00%
Ms. Deanna D. Strable-Soethout
Ms. Deanna D. Strable-Soethout
Independent Director
Independent Director
1.65K
+601.00%
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Independent Director
Independent Director
639.00
+639.00%
Umsatzaufteilung
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Premiums
41.79B
0.00%
Product revenue
6.16B
0.00%
Service fees
2.14B
0.00%
Reconciliation
624.00M
0.00%
Operating revenue - affliated
0.00
0.00%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Premiums
41.79B
0.00%
Product revenue
6.16B
0.00%
Service fees
2.14B
0.00%
Reconciliation
624.00M
0.00%
Operating revenue - affliated
0.00
0.00%
Aktionärsstatistik
Aktualisiert: Tue, Nov 18
Aktualisiert: Tue, Nov 18
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
10.30%
BlackRock Institutional Trust Company, N.A.
5.31%
State Street Investment Management (US)
4.66%
Wellington Management Company, LLP
2.98%
Sanders Capital, LLC
2.60%
Andere
74.15%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
10.30%
BlackRock Institutional Trust Company, N.A.
5.31%
State Street Investment Management (US)
4.66%
Wellington Management Company, LLP
2.98%
Sanders Capital, LLC
2.60%
Andere
74.15%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
49.98%
Investment Advisor/Hedge Fund
30.92%
Pension Fund
2.77%
Bank and Trust
2.33%
Hedge Fund
2.17%
Research Firm
2.16%
Sovereign Wealth Fund
1.41%
Family Office
0.27%
Family Office
0.27%
Andere
7.73%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
3063
205.92M
97.95%
+22.74K
2025Q3
3138
205.95M
97.05%
-3.45M
2025Q2
3116
209.73M
96.68%
-566.57K
2025Q1
3115
208.90M
96.86%
-10.38M
2024Q4
3105
212.00M
93.76%
+298.05K
2024Q3
2993
212.22M
94.67%
-2.15M
2024Q2
2959
214.26M
94.25%
+1.04M
2024Q1
2925
213.00M
94.22%
-6.19M
2023Q4
2869
213.96M
93.90%
-1.80M
2023Q3
2746
215.71M
93.86%
-2.17M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
22.88M
10.3%
+133.40K
+0.59%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
11.81M
5.31%
+190.00K
+1.64%
Sep 30, 2025
State Street Investment Management (US)
10.35M
4.66%
-222.81K
-2.11%
Sep 30, 2025
Wellington Management Company, LLP
6.62M
2.98%
+303.10K
+4.80%
Sep 30, 2025
Sanders Capital, LLC
5.77M
2.6%
-56.29K
-0.97%
Sep 30, 2025
T. Rowe Price Associates, Inc.
5.50M
2.48%
-2.25M
-29.00%
Sep 30, 2025
Geode Capital Management, L.L.C.
5.14M
2.31%
+50.02K
+0.98%
Sep 30, 2025
Artisan Partners Limited Partnership
4.58M
2.06%
+901.63K
+24.53%
Sep 30, 2025
First Eagle Investment Management, L.L.C.
4.00M
1.8%
+798.46K
+24.95%
Sep 30, 2025
Harris Associates L.P.
3.19M
1.44%
+902.06K
+39.43%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares U.S. Healthcare Providers ETF
4.43%
Monarch Dividend Plus Index ETF
3.25%
John Hancock Fundamental All Cap Core ETF
2.45%
GMO US Quality ETF
2.35%
VictoryShares Free Cash Flow ETF
2.32%
Bushido Capital US Equity ETF
2.2%
State Street SPDR S&P Health Care Services ETF
2.11%
First Eagle Global Equity ETF
2.03%
First Trust Total US Market AlphaDEX ETF
1.75%
First Trust Health Care Alphadex Fund
1.71%
Mehr Anzeigen
iShares U.S. Healthcare Providers ETF
Anteil4.43%
Monarch Dividend Plus Index ETF
Anteil3.25%
John Hancock Fundamental All Cap Core ETF
Anteil2.45%
GMO US Quality ETF
Anteil2.35%
VictoryShares Free Cash Flow ETF
Anteil2.32%
Bushido Capital US Equity ETF
Anteil2.2%
State Street SPDR S&P Health Care Services ETF
Anteil2.11%
First Eagle Global Equity ETF
Anteil2.03%
First Trust Total US Market AlphaDEX ETF
Anteil1.75%
First Trust Health Care Alphadex Fund
Anteil1.71%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
5.24B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Oct 15, 2025
ELV.NB Final Cash Dividend of gross USD 1.71 paid on Dec 19, 2025 going ex on Dec 05, 2025
Dec 05, 2025
Dec 19, 2025
Dec 05, 2025
Jul 17, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Sep 25, 2025 going ex on Sep 10, 2025
Sep 10, 2025
Sep 25, 2025
Sep 10, 2025
Apr 22, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Jun 25, 2025 going ex on Jun 10, 2025
Jun 10, 2025
Jun 25, 2025
Jun 10, 2025
Jan 23, 2025
ELV.NB Interim Cash Dividend of gross USD 1.71 paid on Mar 25, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 25, 2025
Mar 10, 2025
Oct 17, 2024
ELV.NB Final Cash Dividend of gross USD 1.63 paid on Dec 20, 2024 going ex on Dec 05, 2024
Dec 05, 2024
Dec 20, 2024
Dec 05, 2024
Jul 17, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Sep 25, 2024 going ex on Sep 10, 2024
Sep 10, 2024
Sep 25, 2024
Sep 10, 2024
Apr 18, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Jun 25, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 25, 2024
Jun 10, 2024
Jan 26, 2024
ELV.NB Interim Cash Dividend of gross USD 1.63 paid on Mar 22, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 22, 2024
Mar 07, 2024
Oct 18, 2023
ELV.NB Final Cash Dividend of gross USD 1.48 paid on Dec 21, 2023 going ex on Dec 05, 2023
Dec 06, 2023
Dec 21, 2023
Dec 05, 2023
Jul 19, 2023
ELV.NB Interim Cash Dividend of gross USD 1.48 paid on Sep 22, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 22, 2023
Sep 07, 2023
Mehr Anzeigen
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
